155 related articles for article (PubMed ID: 17981007)
1. Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay.
Weber H; Claffey J; Hogan M; Pampillón C; Tacke M
Toxicol In Vitro; 2008 Mar; 22(2):531-4. PubMed ID: 17981007
[TBL] [Abstract][Full Text] [Related]
2. Pseudo-halide derivatives of titanocene: synthesis and cytotoxicity studies.
Claffey J; Deally A; Gleeson B; Hogan M; Méndez LM; Müller-Bunz H; Patil S; Wallis D; Tacke M
Metallomics; 2009 Nov; 1(6):511-7. PubMed ID: 21305159
[TBL] [Abstract][Full Text] [Related]
3. Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies.
Hickey T; Claffey J; Fitzpatrick E; Hogan M; Pampillón C; Tacke M
Invest New Drugs; 2007 Oct; 25(5):425-33. PubMed ID: 17516024
[TBL] [Abstract][Full Text] [Related]
4. Oxali-titanocene Y: a potent anticancer drug.
Claffey J; Hogan M; Müller-Bunz H; Pampillón C; Tacke M
ChemMedChem; 2008 May; 3(5):729-31. PubMed ID: 18186097
[No Abstract] [Full Text] [Related]
5. Synthesis and cytotoxicity studies of new dimethylamino-functionalised and aryl-substituted titanocene anti-cancer agents.
Pampillón C; Claffey J; Strohfeldt K; Tacke M
Eur J Med Chem; 2008 Jan; 43(1):122-8. PubMed ID: 17412456
[TBL] [Abstract][Full Text] [Related]
6. Bioorganometallic fulvene-derived titanocene anti-cancer drugs.
Strohfeldt K; Tacke M
Chem Soc Rev; 2008 Jun; 37(6):1174-87. PubMed ID: 18497930
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity studies of new morpholino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs.
Hogan M; Claffey J; Pampillón C; Tacke M
Med Chem; 2008 Mar; 4(2):91-9. PubMed ID: 18336326
[TBL] [Abstract][Full Text] [Related]
8. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells.
Liu S; Wu P; Ye D; Huang Y; Zhou X; Li Y; Cai L
Pharmacology; 2009; 84(1):17-23. PubMed ID: 19478549
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitors derived from thalidomide.
Noguchi T; Fujimoto H; Sano H; Miyajima A; Miyachi H; Hashimoto Y
Bioorg Med Chem Lett; 2005 Dec; 15(24):5509-13. PubMed ID: 16183272
[TBL] [Abstract][Full Text] [Related]
10. Dimethyl titanocene Y: a valuable precursor for libraries of cytotoxic titanocene derivatives.
Immel TA; Martin JT; Dürr CJ; Groth U; Huhn T
J Inorg Biochem; 2010 Aug; 104(8):863-7. PubMed ID: 20452674
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
[TBL] [Abstract][Full Text] [Related]
12. Influence of angiogenesis inhibitors on endothelial cell morphology in vitro.
Friis T; Hansen AB; Houen G; Engel AM
APMIS; 2006 Mar; 114(3):211-24. PubMed ID: 16643188
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-angiogenesis activity of coumarin derivatives.
Lee S; Sivakumar K; Shin WS; Xie F; Wang Q
Bioorg Med Chem Lett; 2006 Sep; 16(17):4596-9. PubMed ID: 16793260
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of (+)-hedychilactone A and its analogs from (+)-sclareolide.
Oh S; Jeong IH; Shin WS; Wang Q; Lee S
Bioorg Med Chem Lett; 2006 Mar; 16(6):1656-9. PubMed ID: 16384699
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
[TBL] [Abstract][Full Text] [Related]
16. Titanocene difluorides with improved cytotoxic activity.
Eger S; Immel TA; Claffey J; Müller-Bunz H; Tacke M; Groth U; Huhn T
Inorg Chem; 2010 Feb; 49(4):1292-4. PubMed ID: 20055428
[TBL] [Abstract][Full Text] [Related]
17. Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer.
Elie BT; Fernández-Gallardo J; Curado N; Cornejo MA; Ramos JW; Contel M
Eur J Med Chem; 2019 Jan; 161():310-322. PubMed ID: 30368130
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitors.
Sano H; Noguchi T; Miyajima A; Hashimoto Y; Miyachi H
Bioorg Med Chem Lett; 2006 Jun; 16(11):3068-72. PubMed ID: 16513348
[TBL] [Abstract][Full Text] [Related]
19. Organometallic ruthenium(II) arene compounds with antiangiogenic activity.
Nowak-Sliwinska P; van Beijnum JR; Casini A; Nazarov AA; Wagnieres G; van den Bergh H; Dyson PJ; Griffioen AW
J Med Chem; 2011 Jun; 54(11):3895-902. PubMed ID: 21534534
[TBL] [Abstract][Full Text] [Related]
20. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN
Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
